Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lingling Tang

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Life Sciences|February 15, 2020
Decreasing Arl4c expression by inhibition of AKT signal in human lung adenocarcinoma cellsYipeng Sun, Zhuhua Zhang, Fenfen Xiang, et al.
Communications Biology|April 14, 2021
Gut mycobiota alterations in patients with COVID-19 and H1N1 infections and their associations with clinical featuresLongxian Lv, Silan Gu, Huiyong Jiang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 28, 2017
Benefit of Early Initiation of Neuraminidase Inhibitor Treatment to Hospitalized Patients With Avian Influenza A(H7N9) VirusShufa Zheng, Lingling Tang, Hainv Gao, et al.
Frontiers of Medicine|August 8, 2020
Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19Lingling Tang, Yingan Jiang, Mengfei Zhu, et al.
Communications Physics|November 14, 2022
Use of temporal contact graphs to understand the evolution of COVID-19 through contact tracing dataMincheng Wu, Chao Li, Zhangchong Shen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 5, 2020
Alterations of the Gut Microbiota in Patients With Coronavirus Disease 2019 or H1N1 InfluenzaSilan Gu, Yanfei Chen, Zhengjie Wu, et al.
Artificial Organs|December 16, 2020
Effect of artificial liver blood purification treatment on the survival of critical ill COVID-19 patientsXiahong Dai, Yimin Zhang, Liang Yu, et al.
Clinical and Translational Medicine|February 26, 2021
Evaluation of the safety and efficacy of using human menstrual blood-derived mesenchymal stromal cells in treating severe and critically ill COVID-19 patients: An exploratory clinical trialXiaowei Xu, Wanli Jiang, Lijun Chen, et al.
Imeta|August 13, 2024
MASS cohort: Multicenter, longitudinal, and prospective study of the role of microbiome in severe pneumonia and host susceptibilityXin Wei, Li Guo, Hongliu Cai, et al.
The Lancet. Infectious Diseases|November 25, 2023
Oral VV116 versus placebo in patients with mild-to-moderate COVID-19 in China: a multicentre, double-blind, phase 3, randomised controlled studyXiaohong Fan, Xiahong Dai, Yun Ling, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Life Sciences|February 15, 2020
Decreasing Arl4c expression by inhibition of AKT signal in human lung adenocarcinoma cellsYipeng Sun, Zhuhua Zhang, Fenfen Xiang, et al.
Communications Biology|April 14, 2021
Gut mycobiota alterations in patients with COVID-19 and H1N1 infections and their associations with clinical featuresLongxian Lv, Silan Gu, Huiyong Jiang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 28, 2017
Benefit of Early Initiation of Neuraminidase Inhibitor Treatment to Hospitalized Patients With Avian Influenza A(H7N9) VirusShufa Zheng, Lingling Tang, Hainv Gao, et al.
Frontiers of Medicine|August 8, 2020
Clinical study using mesenchymal stem cells for the treatment of patients with severe COVID-19Lingling Tang, Yingan Jiang, Mengfei Zhu, et al.
Communications Physics|November 14, 2022
Use of temporal contact graphs to understand the evolution of COVID-19 through contact tracing dataMincheng Wu, Chao Li, Zhangchong Shen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 5, 2020
Alterations of the Gut Microbiota in Patients With Coronavirus Disease 2019 or H1N1 InfluenzaSilan Gu, Yanfei Chen, Zhengjie Wu, et al.
Artificial Organs|December 16, 2020
Effect of artificial liver blood purification treatment on the survival of critical ill COVID-19 patientsXiahong Dai, Yimin Zhang, Liang Yu, et al.
Clinical and Translational Medicine|February 26, 2021
Evaluation of the safety and efficacy of using human menstrual blood-derived mesenchymal stromal cells in treating severe and critically ill COVID-19 patients: An exploratory clinical trialXiaowei Xu, Wanli Jiang, Lijun Chen, et al.
Imeta|August 13, 2024
MASS cohort: Multicenter, longitudinal, and prospective study of the role of microbiome in severe pneumonia and host susceptibilityXin Wei, Li Guo, Hongliu Cai, et al.
The Lancet. Infectious Diseases|November 25, 2023
Oral VV116 versus placebo in patients with mild-to-moderate COVID-19 in China: a multicentre, double-blind, phase 3, randomised controlled studyXiaohong Fan, Xiahong Dai, Yun Ling, et al.
Pageof 9